OA08911A - Diagnosis and treatment of double-stranded RNA deficiency states. - Google Patents

Diagnosis and treatment of double-stranded RNA deficiency states.

Info

Publication number
OA08911A
OA08911A OA59419A OA59419A OA08911A OA 08911 A OA08911 A OA 08911A OA 59419 A OA59419 A OA 59419A OA 59419 A OA59419 A OA 59419A OA 08911 A OA08911 A OA 08911A
Authority
OA
OAPI
Prior art keywords
diagnosis
double
treatment
stranded rna
deficiency states
Prior art date
Application number
OA59419A
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of OA08911A publication Critical patent/OA08911A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
OA59419A 1987-09-04 1988-09-05 Diagnosis and treatment of double-stranded RNA deficiency states. OA08911A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9352387A 1987-09-04 1987-09-04

Publications (1)

Publication Number Publication Date
OA08911A true OA08911A (en) 1989-10-31

Family

ID=22239406

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59419A OA08911A (en) 1987-09-04 1988-09-05 Diagnosis and treatment of double-stranded RNA deficiency states.

Country Status (15)

Country Link
JP (1) JPH0825884B2 (en)
KR (1) KR890005277A (en)
CN (1) CN1031651A (en)
AU (3) AU2186488A (en)
CA (1) CA1336683C (en)
DK (1) DK491088A (en)
FI (1) FI884069A (en)
IL (1) IL87664A (en)
NO (1) NO883868L (en)
NZ (1) NZ226033A (en)
OA (1) OA08911A (en)
PH (1) PH26320A (en)
PT (1) PT88415B (en)
RU (1) RU2001917C1 (en)
ZA (1) ZA886581B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1088344C (en) * 1997-10-17 2002-07-31 青岛市卫生防疫站 Process for preparing selenium or zinc enriched earthworm dry powder or extract
US20060035859A1 (en) * 2003-05-16 2006-02-16 Hemispherx Biopharma Treating severe and acute viral infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024222A (en) * 1973-10-30 1977-05-17 The Johns Hopkins University Nucleic acid complexes
JPS57200310A (en) * 1981-05-26 1982-12-08 Merck & Co Inc Local application of interferon inducer
AU1820388A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles

Also Published As

Publication number Publication date
CA1336683C (en) 1995-08-15
CN1031651A (en) 1989-03-15
KR890005277A (en) 1989-05-13
NO883868L (en) 1989-03-06
AU2186488A (en) 1989-03-09
RU2001917C1 (en) 1993-10-30
DK491088D0 (en) 1988-09-02
ZA886581B (en) 1989-04-26
JPH0825884B2 (en) 1996-03-13
JPH01131118A (en) 1989-05-24
NZ226033A (en) 1999-08-30
PH26320A (en) 1992-04-29
DK491088A (en) 1989-03-05
FI884069A0 (en) 1988-09-02
AU1001495A (en) 1995-03-30
PT88415A (en) 1989-07-31
PT88415B (en) 1992-10-30
NO883868D0 (en) 1988-08-30
IL87664A0 (en) 1989-02-28
AU1736692A (en) 1992-07-30
FI884069A (en) 1989-03-05
IL87664A (en) 1995-03-15

Similar Documents

Publication Publication Date Title
EP0205579A4 (en) Methods and compositions useful in the diagnosis and treatment of autoimmune diseases.
GB8807775D0 (en) Coagulation treatment of fluids
EP0252940A4 (en) Anti-sense rna for treatment of retroviral disease states.
GB8718422D0 (en) Chemical treatment
OA08911A (en) Diagnosis and treatment of double-stranded RNA deficiency states.
IL95751A0 (en) Dna sequences of the wunl gene and their use
ZA883975B (en) Treatment and diagnosis of footrot using the basic protease of b.nodosus
IE882676L (en) Diagnosis and treatment of double-stranded rna deficiency states
EP0411900A3 (en) Treatment of conditions involving excessive eating
AU1162788A (en) Oxime-ethers of 2,6-dioxobicyclo-(3.3.0)octanones for treatment of heart and circulation diseases
AU8094887A (en) Water treatment compositions and processes
AU4849997A (en) Diagnosis and treatment of double stranded deficiency states
AU2395288A (en) Metoprolol in the treatment and prophylaxis of heart disease
EP0411901A3 (en) Treatment of conditions involving excessive eating
PL267042A2 (en) Biological sewage treatment method
IE881524L (en) Preparation of double-stranded dna
PH25733A (en) 5-aryl-3h-1,2,4-triazol-3-ones, their use in the treatment of neurogenerative disorders
PL267073A1 (en) Mechanical and biological sewage treatment station
ZA889072B (en) Surgical swab and its production
EP0269024A3 (en) Use of 3-methyl-4-oxothiazolidin-2-ylidene-acetamide derivatives in the treatment of aids
GB8502680D0 (en) Biological treatment
GB8718585D0 (en) Treatment
GB8719190D0 (en) Treatment
GB8715943D0 (en) Treatment
GB8712248D0 (en) Treatment